Both in Biotechnology
Silexion Therapeutics vs PharmaCyte Biotech
Over the past year SLXN returned −99.6% and PMCB returned −66.0%; their daily moves had a correlation of 0.19.
SLXN −99.6% PMCB −66.0%Growth of $1, one year, split-adjusted
| Metric | SLXN | PMCB |
|---|---|---|
| Price | $0.1532 | $0.3347 |
| Market cap | $2.2M | $3.6M |
| Today | −7.54% | −2.45% |
| 1 month | −51.9% | −20.1% |
| 6 months | −97.6% | −55.4% |
| Year to date | −99.2% | −53.8% |
| 1 year | −99.6% | −66.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $30.5M |
| Dividend yield | — | — |
| Volatility (60d) | 240.6% | 61.5% |
| Short % of float | 3.5% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).